Who is sponsoring NCT04775628?

NCT04775628 is sponsored by Dr. Rob Sillevis,.

What drugs are being tested in NCT04775628?

Interventions in NCT04775628: Inferior glide humerus in GH joint.

What condition does NCT04775628 study?

NCT04775628 studies Asymptomatic Condition.

Is NCT04775628 still recruiting?

NCT04775628 is currently completed. Last updated 7 April 2022.

Last reviewed 2022-04-07 · How we verify

NCT04775628

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Forces and Translation Distance During an Inferior Glide of the Shoulder

Completed NA Last updated 7 April 2022

What this trial tests

NA trial testing Inferior glide humerus in GH joint in Asymptomatic Condition in 64 participants. Completed in 1 May 2019.

Timeline

1 June 2018

Primary endpoint
1 November 2018

1 May 2019

Quick facts

Lead sponsor	Dr. Rob Sillevis,
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	diagnostic
Enrollment	64
Start date	1 June 2018
Primary completion	1 November 2018
Estimated completion	1 May 2019
Sites	1 location across United States

Drugs / interventions tested

Inferior glide humerus in GH joint

Conditions studied

Asymptomatic Condition — all drugs for Asymptomatic Condition →

Sponsor

Dr. Rob Sillevis,

Who can join

Adults 18 to 65, any sex, with Asymptomatic Condition. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study evaluates the force and translation distance in the GH joint during a manual inferior glide of the humerus.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Asymptomatic Condition

Currently open trials in the same condition.

NCT05911828 — A Study to Determine Safety, Tolerability, and Pharmacokinetics of Different Orally Administered Regimens of the Combina · Phase 1 · recruiting
NCT07267507 — Accessory Movements and Associated Factors During Active Cervical Range of Motion · active not recruiting
NCT06215040 — The Treatment Effect for Asymptomatic Common Bile Duct Stone · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04775628 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Dr. Rob Sillevis,
Last refreshed: 7 April 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04775628.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing